Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Genentech, Inc.
Indiana University
Cambridge University Hospitals NHS Foundation Trust
Corvus Pharmaceuticals, Inc.
Celldex Therapeutics